8th Annual Conference on Head and Neck Cancer

描述（由申请人提供）：将于2012年7月21日至25日在加拿大安大略多伦多举行的第八届头颈癌国际会议旨在促进从业人员、受训人员和研究人员之间的讨论，重点是如何协作、多学科治疗和康复可以为头颈癌患者带来最佳的肿瘤学、功能和生活质量结局。美国头颈部癌症协会每四年赞助一次会议，有来自四个专业的1500多名与会者（2008年有2000名与会者）参加，代表了医学肿瘤学、放射肿瘤学和头颈外科学的学科，以确保专业内部和专业之间的教育互动，加强多学科的合作关系。会议的目标包括i）进一步了解和确定我们对头颈癌护理的理解中的差距，并促进所代表的多个学科内部和之间的这些领域的研究; ii）认识到护士、言语病理学家、听力学家、营养学家、社会工作者、疼痛专家、心理健康从业人员、物理治疗师的重要作用，牙科肿瘤学家在实现最大的功能结果和适当的功能评估和新的治疗方案的功能结果的报告，和iii）提供与新兴的研究突破，帮助我们更好地了解头颈癌的发病机制和治疗的熟悉。总的来说，会议旨在促进从业人员，学员和研究人员之间的讨论，重点是如何协作，多学科治疗和康复可以导致最好的肿瘤，功能和生活质量的结果，为头部和 颈部癌症患者。我们在此申请中要求资金，以便1）尽可能公平地向世界各地的头颈部肿瘤学从业人员传播信息，使他们的患者可能从该领域的最新发展中受益; 2）确保初级研究人员，居民，研究员和医学生的机会; 3）允许来自世界各地的参与者，包括少数民族和发展中国家的代表。 公共卫生相关性：第八届国际头颈癌会议是每四年举行一次的系列会议中的下一个预定会议。国际会议是最重要的国际跨学科会议，集中在一次会议上，讨论与头颈癌相关的主题。这些主题包括分子遗传学，肿瘤细胞生物学，免疫学，基因治疗，器官保留手术，放射学和成像，放疗，化疗，化学预防，重建手术和生活质量问题。该会议的目的是1）促进从业人员，学员和研究人员之间的讨论，重点是如何协作，多学科治疗和康复可以导致最好的肿瘤，功能和生活质量的结果， 颈癌患者; 2）将临床研究人员、遗传学家、免疫学家以及分子和细胞生物学家聚集在一起，分享头颈癌的最新进展，确定未来研究所需的领域，并将这些信息传播给相关领域的更广泛的研究人员。在一个行业支持下降的时代，需要资金来支持我们的专业学员、初级调查员、少数民族和国际参与者未来的差旅费。

DESCRIPTION (provided by applicant): The 8th International Conference on Head and Neck Cancer to be held July 21-25, 2012 in Toronto, Ontario, Canada is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. The American Head and Neck Cancer sponsors this meeting every four years with participation of over 1500 attendees (2000 attendees in 2008) from four specialties representing the disciplines of medical oncology radiation oncology, radiology and head and neck surgery in order to ensure educational interaction within and between specialties that can strengthen multi-disciplinary collaborative relationships. Objectives for the meeting include i) to further understanding and identify gaps in our understanding of Head and Neck Cancer care and foster research in those areas within and between the multiple disciplines represented; ii) to recognize the important role of nurses, speech pathologists, audiologists, nutritionists, social workers, pain specialists, mental health practitioners, physical therapists, dental oncologists in achieving maximal functional outcomes and proper functional assessment and reporting of functional results of new treatments programs, and iii) to provide familiarity with emerging research breakthroughs that are helping us to better understand the pathogenesis and treatment of head and neck cancer. Overall, the conference is designed to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients. We request funds in this application in order to 1) disseminate information as equitably as possible to practitioners of head and neck oncology around the world so that their patients may potentially benefit from the most current developments in the field; 2) ensure opportunity for junior investigators, residents, fellows and medical students; and 3) allow participants from around the world including minorities and representatives from developing nations. PUBLIC HEALTH RELEVANCE: The 8th International Conference on Head and Neck Cancer is the next scheduled conference in a series held every four years. The International Conferences are the most important international interdisciplinary conferences focused, in a single meeting, on topics related to head and neck cancer. These topics include molecular genetics, tumor cell biology, immunology, gene therapy, organ-sparing surgery, radiology and imaging, radiotherapy, chemotherapy, chemoprevention, reconstructive surgery, and quality of life issues. The conference is designed 1) to facilitate discussion among practitioners, trainees, and researchers with an emphasis on how collaborative, multi-disciplinary treatment and rehabilitation can lead to the best oncologic, functional and quality of life outcomes for head and neck cancer patients; 2) to bring together clinical investigators, geneticists, immunologists, and molecular and cellular biologists to share recent advances in head and neck cancer, identify needed areas of future research and disseminate this information to the larger community of investigators in related fields. In an era of declining industry support, funds are requested to support travel expenses for the future of our specialty - trainees, junior investigators, minoritie and international participants.